PLRXPLIANT THERAPEUTICS, INC.vs its industry peers
A metric-by-metric comparison of PLIANT THERAPEUTICS, INC. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PLRX본 종목 | $53M#8 | — | 0.4x#1 | — | — | -29.0%#10 | — | 101.6%#1 | — | — | -49.3%#10 | — |
| RNTX | $58M#1 | — | 1.0x#4 | — | — | 20.7%#3 | — | -90.4%#5 | — | — | -56.8%#12 | — |
| NMAD | $57M#2 | — | 2.4x#6 | 286.6x#5 | — | -69.5%#12 | -2553.8%#3 | -25.4%#2 | — | — | -15.8%#4 | — |
| RNXT | $57M#3 | — | 6.4x#10 | 50.8x#2 | 2511.6%#1 | -26.7%#9 | -1114.0%#2 | -124.4%#8 | — | — | 14.5%#2 | — |
| OSTX | $57M#4 | — | — | — | — | -223.7%#16 | — | — | — | — | -32.7%#7 | — |
| BOLD | $55M#5 | — | 0.8x#3 | — | — | 11.0%#5 | — | -88.2%#4 | — | — | 77.4%#1 | — |
| HRTX | $55M#6 | — | 8.0x#11 | 0.4x#1 | 7.4%#4 | -42.9%#11 | -1.6%#1 | -289.5%#10 | — | — | -74.8%#14 | — |
| TLPH | $55M#7 | — | 3.8x#8 | 1946.5x#9 | — | -9.9%#7 | -48157.1%#9 | -99.2%#6 | — | — | -19.8%#5 | — |
| YARW | $52M#9 | 2.3x#1 | 2.4x#5 | 91.3x#3 | 13.8%#3 | 33.5%#2 | -5219.1%#4 | -120.0%#7 | — | — | 10.5%#3 | — |
| CALC | $52M#10 | — | 9.4x#12 | — | — | -115.8%#15 | — | -536.2%#12 | — | — | — | — |
| ANVS | $52M#11 | — | — | — | — | -17.3%#8 | — | — | — | — | -42.1%#9 | — |
| GANX | $51M#12 | — | 4.5x#9 | 925.4x#8 | -58.4%#6 | 1.2%#6 | -33908.5%#7 | -178.5%#9 | — | — | -40.5%#8 | — |
| IBIO | $51M#13 | — | 0.6x#2 | 509.6x#7 | -75.0%#7 | -78.7%#14 | -35141.0%#8 | -38.3%#3 | — | — | -50.3%#11 | — |
| CLNN | $50M#14 | — | — | 250.2x#4 | -41.5%#5 | 33.6%#1 | -11541.5%#5 | — | — | — | — | — |
| SER | $50M#15 | — | — | 384.9x#6 | 132.1%#2 | -72.2%#13 | -18478.5%#6 | — | — | 5#1 | -59.3%#13 | — |
| HOWL | $49M#16 | — | 3.0x#7 | — | — | 13.7%#4 | — | -373.3%#11 | -229.9%#1 | — | -22.2%#6 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-11-03.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice